Status:
UNKNOWN
Effects of Treatment With ENF (Electro Neuro Feedback) in the Reduction of Post-surgical Hematoma in Patients Undergoing Hip Replacement: Evaluation With Ultrasound Method
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Post-surgical Hematoma, Hip Replacement , Surgery
Eligibility:
All Genders
35-85 years
Brief Summary
The study evaluates patients with clinical evidence of post-surgical hematoma / seroma after hip replacement surgery. These patients will undergo ultrasound evaluation in the 4th (+/- 2) day post surg...
Eligibility Criteria
Inclusion
- Gender: male and female
- Age: 35-85 years include
- Entry into the hospital rehabilitation program lasting at least 5 days following hip replacement surgery
- Absence in history of neurological or psychiatric disorders.
- Signature of the Informed Consent and consent to collaborate in all the procedures of the study
Exclusion
- Presence of severe neurological / psychiatric pathologies
- to sign the Informed Consense
- of serious cardiological pathologies that can compromise patient safety
- of Pace Maker or spinal cord stimulators or other subcutaneous electronic instruments
- of active tumors in the treatment area
Key Trial Info
Start Date :
November 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05196321
Start Date
November 11 2021
End Date
July 20 2023
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi -San Siro
Milan, Italy, 20161